Androgen Deprivation Therapy Toxicity and Management for Men Receiving Radiation Therapy

المؤلفون المشاركون

Johnson, Matthew E.
Buyyounouski, Mark K.

المصدر

Prostate Cancer

العدد

المجلد 2012، العدد 2012 (31 ديسمبر/كانون الأول 2012)، ص ص. 1-8، 8ص.

الناشر

Hindawi Publishing Corporation

تاريخ النشر

2012-12-30

دولة النشر

مصر

عدد الصفحات

8

التخصصات الرئيسية

الأمراض
الطب البشري

الملخص EN

Androgen deprivation therapy is commonly used in combination with radiotherapy as part of the definitive treatment for men with clinically localized and locally advanced prostate cancer.

Androgen deprivation has been associated with a wide range of iatrogenic effects impacting a variety of body systems including metabolic, musculoskeletal, cardiovascular, neurocognitive, and sexual.

This review aims to provide the radiation oncology community with the knowledge to monitor and manage androgen deprivation therapy toxicity in an effort to provide the highest level of care for patients and to minimize the iatrogenic effects of androgen deprivation as much as possible.

نمط استشهاد جمعية علماء النفس الأمريكية (APA)

Johnson, Matthew E.& Buyyounouski, Mark K.. 2012. Androgen Deprivation Therapy Toxicity and Management for Men Receiving Radiation Therapy. Prostate Cancer،Vol. 2012, no. 2012, pp.1-8.
https://search.emarefa.net/detail/BIM-482381

نمط استشهاد الجمعية الأمريكية للغات الحديثة (MLA)

Johnson, Matthew E.& Buyyounouski, Mark K.. Androgen Deprivation Therapy Toxicity and Management for Men Receiving Radiation Therapy. Prostate Cancer No. 2012 (2012), pp.1-8.
https://search.emarefa.net/detail/BIM-482381

نمط استشهاد الجمعية الطبية الأمريكية (AMA)

Johnson, Matthew E.& Buyyounouski, Mark K.. Androgen Deprivation Therapy Toxicity and Management for Men Receiving Radiation Therapy. Prostate Cancer. 2012. Vol. 2012, no. 2012, pp.1-8.
https://search.emarefa.net/detail/BIM-482381

نوع البيانات

مقالات

لغة النص

الإنجليزية

الملاحظات

Includes bibliographical references

رقم السجل

BIM-482381